Page last updated: 2024-08-22

cladribine and Genetic Predisposition

cladribine has been researched along with Genetic Predisposition in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lorillon, G; Tazi, A	1
Treon, SP	1
Gratwohl, A; Rimner, T; Tichelli, A; Went, P	1

Reviews

1 review(s) available for cladribine and Genetic Predisposition

Article	Year
How I manage pulmonary Langerhans cell histiocytosis. European respiratory review : an official journal of the European Respiratory Society, 2017, Sep-30, Volume: 26, Issue:145 Topics: Adult; Cladribine; Female; Genetic Predisposition to Disease; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Lung; Lung Diseases; Lung Transplantation; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Phenotype; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Respiratory Function Tests; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2017

Article

Year

How I manage pulmonary Langerhans cell histiocytosis.

European respiratory review : an official journal of the European Respiratory Society, 2017, Sep-30, Volume: 26, Issue:145

Topics: Adult; Cladribine; Female; Genetic Predisposition to Disease; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Lung; Lung Diseases; Lung Transplantation; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Phenotype; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Respiratory Function Tests; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2017

Other Studies

2 other study(ies) available for cladribine and Genetic Predisposition

Article	Year
How I treat Waldenström macroglobulinemia. Blood, 2015, Aug-06, Volume: 126, Issue:6 Topics: Adenine; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Cladribine; Cyclophosphamide; Everolimus; Gene Expression; Genetic Predisposition to Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin M; Male; Middle Aged; Molecular Targeted Therapy; Myeloid Differentiation Factor 88; Nitrogen Mustard Compounds; Oligopeptides; Piperidines; Plasmapheresis; Pyrazines; Pyrazoles; Pyrimidines; Receptors, CXCR4; Rituximab; Sirolimus; Transplantation, Autologous; Vidarabine; Waldenstrom Macroglobulinemia	2015
Concomitant hairy cell and acute myeloid leukemia. European journal of haematology, 2006, Volume: 76, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Daunorubicin; Genetic Predisposition to Disease; Humans; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Stem Cell Transplantation	2006

Article

Year

How I treat Waldenström macroglobulinemia.

Blood, 2015, Aug-06, Volume: 126, Issue:6

Topics: Adenine; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Cladribine; Cyclophosphamide; Everolimus; Gene Expression; Genetic Predisposition to Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin M; Male; Middle Aged; Molecular Targeted Therapy; Myeloid Differentiation Factor 88; Nitrogen Mustard Compounds; Oligopeptides; Piperidines; Plasmapheresis; Pyrazines; Pyrazoles; Pyrimidines; Receptors, CXCR4; Rituximab; Sirolimus; Transplantation, Autologous; Vidarabine; Waldenstrom Macroglobulinemia

2015

Concomitant hairy cell and acute myeloid leukemia.

European journal of haematology, 2006, Volume: 76, Issue:1

Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Daunorubicin; Genetic Predisposition to Disease; Humans; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Stem Cell Transplantation

2006